Study Conduct

Carolinas Research Associates merges with PMG Research

Tuesday, June 11, 2013 02:30 PM

PMG Research has merged with Carolinas Research Associates (CRA). PMG Research, headquartered in Winston-Salem, N.C., is a network of 10 wholly-owned clinical research sites in North Carolina, South Carolina and Tennessee. CRA is located in Charlotte, N.C., where PMG also has a research facility.

More... »

U.S. Clinical Researcher of the Year Competition 2013 open for entries

Monday, June 10, 2013 01:55 PM

The U.S. Clinical Researcher of the Year competition, which recognizes and encourages talented researchers, is open for entries.

More... »

LLS, Dana-Farber partner to bring clinical trials to local communities

Friday, June 7, 2013 01:29 PM

The Leukemia & Lymphoma Society (LLS), a global voluntary health agency, joined the Dana-Farber Cancer Institute in Boston to establish a network of sites for clinical trial testing of blood cancer therapies in community oncology settings across the country.

More... »

HealthCarePoint pledges $10 million in technology services to support ACRES

Tuesday, June 4, 2013 03:03 PM

HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking technology corporation, is pledging more than $10 million in technologies and infrastructure services to ACRES, the Alliance for Clinical Research Excellence and Safety, a Cambridge-based nonprofit organization established to develop a global system for improving quality, safety, ethics and operational effectiveness in drug development and health research.

More... »

TransCelerate reveals collaborative methodology for risk-based monitoring

Monday, June 3, 2013 11:25 AM

TransCelerate BioPharma, an independent nonprofit focused on accelerating the development of new medicines, has released a position paper outlining a methodology for risk-based site monitoring (RBM) that could modernize and streamline the way studies are conducted and monitored.  The RBM position paper reflects TransCelerate's collaborative approach to improve speed, efficiency and capabilities in bringing new therapeutics to patients. 

More... »

Tufts CSDD study: Adoption of adaptive trials increasing

Tuesday, May 28, 2013 02:20 PM

Aptiv Solutions has announced publication of a Tufts Center for the Study of Drug Development (CSDD) report on the adoption and impact of adaptive trial designs, research funded by an unrestricted educational grant from Aptiv.

More... »

Avoca Group holds Quality Summit

Tuesday, May 28, 2013 02:11 PM

The Avoca Group, a Princeton, N.J.-based consulting and research organization specializing in clinical outsourcing and alliance management, held its second annual Avoca Quality Consortium Summit May 8 and 9. Last year, Avoca formed the industry‐wide Avoca Quality Consortium, bringing together quality, outsourcing and operational professionals from member pharma, biotech and CROs to accelerate the development of a best practice approach to quality management and oversight of outsourced clinical research.

More... »

PCORI opens second year of research funding with $81M

Friday, May 17, 2013 10:30 AM

The Patient-Centered Outcomes Research Institute (PCORI), an independent, non-profit organization, opened its second year of funding of patient-centered comparative clinical effectiveness research (CER), revising its broad funding announcements to clarify key review criteria and application definitions.

More... »

Vince & Associates Clinical Research acquired by the Altasciences Group

Wednesday, May 15, 2013 01:40 PM

The Altasciences Group of Quebec has acquired Vince & Associates Clinical Research.

More... »

BIO, ViS Research Institute target pediatric trials

Tuesday, May 14, 2013 01:27 PM

The Biotechnology Industry Organization and the ViS Research Institute have launched an initiative aimed at improving the efficiency of clinical development for pediatric therapeutics. BIO and its member companies will work with ViS to use its online analytics platform to evaluate global pediatric clinical research infrastructure, identify pediatric patient populations and empower clinical research collaboration.

More... »